학술논문

The unique α4(1)/(2)α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtypes
Document Type
Article
Source
In: Journal of Pharmacology and Experimental Therapeutics. (Journal of Pharmacology and Experimental Therapeutics, January 2014, 348(1):46-58)
Subject
Language
English
ISSN
00223565
15210103